Differential microRNA expression in blood in multiple sclerosis

Abstract

Background:

microRNAs (miRNAs) regulate the expression of the genome at the post-transcriptional level. They play a role in autoimmunity and inflammation, and show potential for use as therapeutic targets in many diseases. With the recent detection of miRNAs in body fluids, the possibility for using miRNAs as diagnostic biomarkers has emerged.

Objective:

We assessed whether miRNAs contribute to the altered immune activation state in relapsing–remitting multiple sclerosis (RRMS) patients and investigated the possible use of miRNAs as diagnostic biomarkers in multiple sclerosis (MS).

Methods:

We performed global miRNA expression profiling analysis in peripheral blood mononuclear cells (PBMCs) and selected miRNAs were measured in plasma. We detected expression of miRNAs by real-time qPCR and compared results with cytokines related to inflammation and disease activity. Selected miRNAs were analyzed in PBMC subpopulations, after isolating them by magnetic bead separation.

Results:

We found that among validated miRNAs, let-7d correlated with the pro-inflammatory cytokine interleukin-1B. The miR-145 was 3-fold up-regulated in MS patients; its possible use as a diagnostic biomarker in PBMCs, plasma and serum was confirmed by ROC-curve analysis (Area under the curve (AUC) 0.785, p = 0.0004; 0.785, p = 0.004; 0.981, P < 0.0001, respectively).

Conclusions:

RRMS patients in remission had altered expression of miRNAs. We validated miR-145 as a potential diagnostic biomarker for the diagnosis of MS in blood, plasma and serum.

Keywords

Biomarker cell types diagnostics interleukin hematology microRNA miRNA multiple sclerosis relapsing–remitting multiple sclerosis serological test

Get full access to this article

View all access options for this article.

References

Compston

Coles

. Multiple sclerosis. Lancet 2008; 372: 1502–1517.

Sawcer

Hellenthal

Pirinen

. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature 2011; 476: 214–219.

Loma

Heyman

. Multiple sclerosis: Pathogenesis and treatment. Curr Neuropharmacol 2011; 9: 409–416.

Hesse

Krakauer

Lund

. Breakthrough disease during interferon-[beta] therapy in MS: No signs of impaired biologic response. Neurology 2010; 74: 1455–1462.

Filipowicz

Bhattacharyya

Sonenberg

. Mechanisms of post-transcriptional regulation by microRNAs: Are the answers in sight? Nat Rev Genet 2008; 9: 102–114.

O’Connell

Rao

Chaudhuri

. Physiological and pathological roles for microRNAs in the immune system. Nat Rev Immunol 2010; 10: 111–122.

Jeker

Bluestone

. Small RNA regulators of T cell-mediated autoimmunity. J Clin Immunol 2010; 30: 347–357.

Otaegui

Baranzini

Armananzas

. Differential micro RNA expression in PBMC from multiple sclerosis patients. PLoS One 2009; 4: e6309.

Keller

Leidinger

Lange

. Multiple sclerosis: MicroRNA expression profiles accurately differentiate patients with relapsing–remitting disease from healthy controls. PLoS One 2009; 4: e7440.

10.

Martinelli-Boneschi

Fenoglio

Brambilla

. MicroRNA and mRNA expression profile screening in multiple sclerosis patients to unravel novel pathogenic steps and identify potential biomarkers. Neurosci Lett 2012; 508: 4–8.

11.

Fenoglio

Cantoni

. Expression and genetic analysis of miRNAs involved in CD4+ cell activation in patients with multiple sclerosis. Neurosci Lett 2011; 504: 9–12.

12.

Cox

Cairns

Gandhi

. MicroRNAs miR-17 and miR-20a inhibit T-cell activation genes and are under-expressed in MS whole blood. PLoS One 2010; 5: e12132.

13.

Liu

Kang

. MicroRNA miR-326 regulates TH-17 differentiation and is associated with the pathogenesis of multiple sclerosis. Nat Immunol 2009; 10: 1252–1259.

14.

Lindberg

Hoffmann

Mehling

. Altered expression of miR-17-5p in CD4+ lymphocytes of relapsing–remitting multiple sclerosis patients. Eur J Immunol 2010; 40: 888–898.

15.

Ferracin

Biondani

. Altered miRNA expression in T regulatory cells in course of multiple sclerosis. J Neuroimmunol 2010; 226: 165–171.

16.

Guerau-de-Arellano

Smith

Godlewski

. Micro-RNA dysregulation in multiple sclerosis favours pro-inflammatory T-cell-mediated autoimmunity. Brain 2011; 134: 3578–3589.

17.

Junker

Krumbholz

Eisele

. MicroRNA profiling of multiple sclerosis lesions identifies modulators of the regulatory protein CD47. Brain 2009; 132: 3342–3352.

18.

Waschbisch

Atiya

Linker

. Glatiramer acetate treatment normalizes deregulated microRNA expression in relapsing–remitting multiple sclerosis. PLoS One 2011; 6: e24604.

19.

Pedersen

Cheng

Wieland

. Interferon modulation of cellular microRNAs as an antiviral mechanism. Nature 2007; 449: 919–922.

20.

Weber

Baxter

Zhang

. The microRNA spectrum in 12 body fluids. Clin Chem 2010; 56: 1733–1741.

21.

Mitchell

Parkin

Kroh

. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 2008; 105: 10513–10518.

22.

Polman

Reingold

Edan

. Diagnostic criteria for multiple sclerosis: 2005 Revisions to the “McDonald Criteria.” Ann Neurol 2005; 58: 840–846.

23.

Romme

Bornsen

Hesse

. Cellular sources of dysregulated cytokines in relapsing–remitting multiple sclerosis. J Neuroinflammation 2012; 9: 215–226.

24.

Mestdagh

Feys

Bernard

. High-throughput stem-loop RT-qPCR miRNA expression profiling using minute amounts of input RNA. Nucleic Acids Res 2008; 36: e143.

25.

Livak

Schmittgen

. Analysis of relative gene expression data using real-time quantitative PCR and the 2(T) (-Delta Delta C) method. Methods 2001; 25: 402–408.

26.

McDonald

Milosevic

Reddi

. Analysis of circulating microRNA: Preanalytical and analytical challenges. Clin Chem 2011; 57: 833–840.

27.

Liu

Chen

Song

. MicroRNA-98 negatively regulates IL-10 production and endotoxin tolerance in macrophages after LPS stimulation. FEBS Lett 2011; 585: 1963–1968.

28.

De Waal

Abrams

Bennett

. Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: An autoregulatory role of IL-10 produced by monocytes. J Exp Med 1991; 174: 1209–1220.

29.

Witwer

Sisk

Gama

. MicroRNA regulation of IFN-beta protein expression: Rapid and sensitive modulation of the innate immune response. J Immunol 2010; 184: 2369–2376.

30.

Haghikia

Hellwig

. Regulated microRNAs in the CSF of patients with multiple sclerosis: A case-control study. Neurology 2012; 79: 2166–2170.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.41 MB